Market Monitor - Chemicals performance - Belgium

Market Monitor

  • Belgium
  • Chemicals/Pharma

1st June 2015

The Belgian chemicals sector is expected to grow in 2015, helped by a weaker euro, lower oil prices and a eurozone rebound.

Market performance snapshots

Belgium

  • Payments take 30 days on average
  • Growth expected to continue in 2015
  • Weakening competitiveness due to high labour costs

In international comparison, the Belgian chemicals sector benefits from a very high degree of specialisation. It includes a wide range of segments, from basic organic and inorganic products to pharmaceuticals, biotechnology, products for agriculture, paints, glues, detergents, cosmetics, rubber and plastics processing and many other specialty products such as chemicals for the photography industry. Chemicals (including pharmaceuticals) account for about 23% of the Belgian manufacturing sector, employing about 87,000 people directly and 144,000 people indirectly. More than 75% of the production is exported, and chemicals account for more than 30% of Belgian exports.

After growing in 2013, the Belgian chemicals sector continued its good performance in 2014. According to the Belgian chemicals association Essenscia, turnover increased 2.4% year-on-year in 2014, to EUR 64.2 billion, due to an increase in volumes as well as higher sales prices. In general, the chemicals sector was able to pass on higher raw materials and energy prices to end-customers. Investments amounted to EUR 1.78 billion (30% of total industrial investments in Belgium). Persistently high investments and high research and development spending are core strengths of this industry.

Compared to other Belgian sectors, the general equity, solvency and liquidity strengths of chemicals and pharmaceuticals companies continue to remain above average. Payments in the Belgian chemicals sector take 30 days on average. The number of payment delays is low, and expected to remain so in 2015. Insolvencies are expected to decrease further in 2015, however below the 6% decline forecast for all Belgian business insolvencies, given the already low number of insolvencies in the chemicals sector. Growth is expected to continue in 2015, helped by a weaker euro, lower oil prices and a eurozone rebound.

However, despite its structural resilience, the Belgian chemicals sector also has some weaknesses: competitiveness is weakening due to the fact that labour costs are among the highest in Europe and competition from China has increased. At the same time, the high export-dependency makes the Belgian chemicals sector susceptible to international risks, such as a potential further escalation of the crisis in Ukraine and the Middle East, a hard landing in China, or a return of the eurozone crisis (e.g. either by Greece leaving the eurozone or a deflationary spiral and liquidity trap).

That said, given the currently robust performance, financial health and low insolvency rate, our underwriting stance remains relaxed for the time being. Buyers are reviewed at least once a year on the basis of new accounts or when new information is received. The latest balance sheet is always requested and we also seek to obtain interim results from more sensitive buyers.

Related documents

Disclaimer

Each publication available on or from our websites, such as, but not limited to webpages, reports, articles, publications, tips and helpful content, trading briefs, infographics, videos (each a “Publication”) is provided for information purposes only and is not intended as a recommendation or advice as to particular transactions, investments or strategies in any way to any reader. Readers must make their own independent decisions, commercial or otherwise, regarding the information provided. While we have made every attempt to ensure that the information contained in any Publication has been obtained from reliable sources, Atradius is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in any Publication is provided ’as is’, with no guarantee of completeness, accuracy, timeliness or of the results obtained from its use, and without warranty of any kind, express or implied. In no event will Atradius, its related partnerships or corporations, or the partners, agents or employees thereof, be liable to you or anyone else for any decision made or action taken in reliance on the information in any Publication, or for any loss of opportunity, loss of profit, loss of production, loss of business or indirect losses, special or similar damages of any kind, even if advised of the possibility of such losses or damages.